SD

Sivasankar Dammalapati

Active Director Director DIN 11515339
DIN 11515339 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivasankar Dammalapati

Data last updated:

Sivasankar Dammalapati is a Director at Amaravati American Institute Of Medical Sciences Private Limited (since 2026). The company operates in Healthcare.

DIN 11515339
Primary Designation Director
Industry Healthcare
First Appointment 31 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Jan 2026Active

Directorship timeline

Open interactive timeline →
Amaravati American Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Sivasankar Dammalapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivasankar Dammalapati

Sivasankar Dammalapati currently holds 1 directorship: Amaravati American Institute Of Medical Sciences Private Limited (Director, since 31 Jan 2026).

Sivasankar Dammalapati was first appointed on 31 Jan 2026 as Director at Amaravati American Institute Of Medical Sciences Private Limited.

The current boards of Sivasankar Dammalapati's companies include Chandrashekararao Mokkapati (Amaravati American Institute Of Medical Sciences Private Limited), Jayashree Gorrepati (Amaravati American Institute Of Medical Sciences Private Limited), Mohanarao Patibandla (Amaravati American Institute Of Medical Sciences Private Limited), Ratna Kumari Chalasani (Amaravati American Institute Of Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available